Morgan Stanley’s Magellan Health Services, Inc. MGLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,195,957
| Closed | -$114M | – | 8398 |
|
|
2021
Q4 | $114M | Buy |
1,195,957
+23,884
| +2% | +$2.26M | 0.01% | 819 |
|
|
2021
Q3 | $111M | Buy |
1,172,073
+806,708
| +221% | +$76.3M | 0.01% | 796 |
|
|
2021
Q2 | $34.4M | Buy |
365,365
+98,395
| +37% | +$9.27M | ﹤0.01% | 1609 |
|
|
2021
Q1 | $24.9M | Buy |
266,970
+193,786
| +265% | +$18.2M | ﹤0.01% | 1715 |
|
|
2020
Q4 | $6.06M | Buy |
73,184
+14,276
| +24% | +$1.13M | ﹤0.01% | 3051 |
|
|
2020
Q3 | $4.46M | Sell |
58,908
-2,717
| -4% | -$202K | ﹤0.01% | 2820 |
|
|
2020
Q2 | $4.5M | Buy |
61,625
+8
| +0% | +$512 | ﹤0.01% | 2783 |
|
|
2020
Q1 | $2.96M | Sell |
61,617
-181,884
| -75% | -$11.7M | ﹤0.01% | 2988 |
|
|
2019
Q4 | $19.1M | Buy |
243,501
+75,136
| +45% | +$5.28M | ﹤0.01% | 1698 |
|
|
2019
Q3 | $10.5M | Buy |
168,365
+40,559
| +32% | +$2.7M | ﹤0.01% | 2077 |
|
|
2019
Q2 | $9.49M | Buy |
127,806
+119,551
| +1,448% | +$8.04M | ﹤0.01% | 2220 |
|
|
2019
Q1 | $545K | Sell |
8,255
-365,085
| -98% | -$23.4M | ﹤0.01% | 4498 |
|
|
2018
Q4 | $21.2M | Buy |
373,340
+157,796
| +73% | +$9.73M | 0.01% | 1409 |
|
|
2018
Q3 | $15.5M | Buy |
215,544
+145,467
| +208% | +$11.7M | ﹤0.01% | 1924 |
|
|
2018
Q2 | $6.72M | Buy |
70,077
+13,524
| +24% | +$1.3M | ﹤0.01% | 2814 |
|
|
2018
Q1 | $6.06M | Sell |
56,553
-42,923
| -43% | -$4.31M | ﹤0.01% | 2821 |
|
|
2017
Q4 | $9.6M | Buy |
99,476
+62,626
| +170% | +$5.54M | ﹤0.01% | 2434 |
|
|
2017
Q3 | $3.18M | Buy |
36,850
+10,499
| +40% | +$828K | ﹤0.01% | 3427 |
|
|
2017
Q2 | $1.92M | Sell |
26,351
-77,222
| -75% | -$5.43M | ﹤0.01% | 3834 |
|
|
2017
Q1 | $7.15M | Sell |
103,573
-135,360
| -57% | -$9.88M | ﹤0.01% | 2521 |
|
|
2016
Q4 | $18M | Buy |
238,933
+83,380
| +54% | +$5.34M | 0.01% | 1643 |
|
|
2016
Q3 | $8.36M | Buy |
155,553
+3,554
| +2% | +$214K | ﹤0.01% | 2169 |
|
|
2016
Q2 | $10M | Buy |
151,999
+46,357
| +44% | +$3.12M | ﹤0.01% | 1982 |
|
|
2016
Q1 | $7.18M | Buy |
105,642
+79,549
| +305% | +$4.79M | ﹤0.01% | 2172 |
|
|
2015
Q4 | $1.61M | Sell |
26,093
-55,066
| -68% | -$2.96M | ﹤0.01% | 3690 |
|
|
2015
Q3 | $4.5M | Buy |
81,159
+57,851
| +248% | +$3.5M | ﹤0.01% | 2753 |
|
|
2015
Q2 | $1.63M | Sell |
23,308
-30,466
| -57% | -$2.07M | ﹤0.01% | 3803 |
|
|
2015
Q1 | $3.81M | Sell |
53,774
-70,306
| -57% | -$4.42M | ﹤0.01% | 3009 |
|
|
2014
Q4 | $7.45M | Sell |
124,080
-49,312
| -28% | -$2.91M | ﹤0.01% | 2340 |
|
|
2014
Q3 | $9.49M | Buy |
173,392
+79,526
| +85% | +$4.56M | ﹤0.01% | 2069 |
|
|
2014
Q2 | $5.84M | Buy |
93,866
+39,643
| +73% | +$2.33M | ﹤0.01% | 2524 |
|
|
2014
Q1 | $3.22M | Sell |
54,223
-12,017
| -18% | -$716K | ﹤0.01% | 3001 |
|
|
2013
Q4 | $3.97M | Buy |
66,240
+15,856
| +31% | +$947K | ﹤0.01% | 2785 |
|
|
2013
Q3 | $3.02M | Buy |
50,384
+2,963
| +6% | +$172K | ﹤0.01% | 2892 |
|
|
2013
Q2 | $2.66M | Buy |
+47,421
| New | +$2.48M | ﹤0.01% | 2916 |
|
Morgan Stanley's MGLN Position: Q1 2022 in Review
Morgan Stanley sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 1,195,957 shares — an estimated $114M sold.
Morgan Stanley first reported a position in MGLN in Q2 2013 and held it in 35 quarters. The position peaked at $114M in Q4 2021. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.
- Morgan Stanley reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
- Morgan Stanley sold 1,195,957 Magellan Health Services, Inc. shares in Q1 2022, an estimated $114M.
- Morgan Stanley first reported a position in Magellan Health Services, Inc. in Q2 2013 and held it in 35 quarters.
- Morgan Stanley's Magellan Health Services, Inc. position peaked at $114M in Q4 2021.
- 0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.
Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.